ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
19 hedge funds and large institutions have $2.74M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
59% more capital invested
Capital invested by funds: $1.72M → $2.74M (+$1.02M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
6% more funds holding
Funds holding: 18 → 19 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Platinum Management
New York
|
+$759K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$629K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.7K |
| 4 |
Goldman Sachs
New York
|
+$5.75K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$3.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$35K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$27K |
| 3 |
Morgan Stanley
New York
|
-$7.32K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$7.14K |
| 5 |
Citigroup
New York
|
-$1K |
ECTE Hedge Fund Activity: Q2 2015 in Review
19 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q2 2015, worth a combined $2.74M — up 59% from $1.72M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ECTE positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Platinum Management, adding an estimated $759K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $35K sold.
- 19 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q2 2015, up from 18 in Q1 2015.
- Funds reported $2.74M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q2 2015, up 59% quarter-over-quarter.
- 4 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q2 2015 and 3 closed out, a net change of +1 holder.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q2 2015 was Platinum Management, an estimated $759K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q2 2015 was Renaissance Technologies, an estimated $35K sold.
Based on aggregated 13F filings for Q2 2015.